Ligands for peroxisome proliferator-activated receptor gamma have potent antitumor effect against human renal cell carcinoma (Q46393805)

21 December 2017

title

Ligands for peroxisome proliferator-activated receptor gamma have potent antitumor effect against human renal cell carcinoma (English)

1 reference

21 December 2017

3

Naoya Masumori

1 reference

21 December 2017

Taiji Tsukamoto

8

object named as

Taiji Tsukamoto

1 reference

21 December 2017

author name string

Jinyang Yuan

1

1 reference

21 December 2017

Atsushi Takahashi

2

1 reference

21 December 2017

Kohsuke Uchida

4

1 reference

21 December 2017

Shin-Ichi Hisasue

5

1 reference

21 December 2017

Hiroshi Kitamura

6

1 reference

21 December 2017

Naoki Itoh

7

1 reference

21 December 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

21 December 2017

published in

Urology

1 reference

21 December 2017

volume

65

1 reference

21 December 2017

issue

3

1 reference

21 December 2017

page(s)

594-599

1 reference

21 December 2017

The nuclear receptor superfamily: the second decade

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.019

Peroxisome proliferator-activated receptors: nuclear control of metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.019

Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.019

Novel sequence determinants in peroxisome proliferator signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.019

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.019

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.019

PPARgamma in monocytes: less pain, any gain?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.019

Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.019

Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.019

PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.019

Establishment of three human renal cell carcinoma cell lines (SMKT-R-1, SMKT-R-2, and SMKT-R-3) and their characters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.019

Study on in vitro invasive potential of renal cell carcinoma cell lines and effect of growth factors (EGF and TGF-beta 1) on their in invasions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.019

Antiproliferative and antiangiogenic activities of genistein in human renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.019

Expression of peroxisome proliferator-activated receptor gamma in renal cell carcinoma and growth inhibition by its agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.019

A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.019

Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.019

Peroxisome proliferator-activated receptor gamma induces pancreatic cancer cell apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.019

PPAR gamma ligand-induced apoptosis through a p53-dependent mechanism in human gastric cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.019

Growth inhibition of esophageal squamous carcinoma cells by peroxisome proliferator-activated receptor-gamma ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.019

Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Delta12, 14-prostaglandin J2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.019

Differential Regulation of Vascular Endothelial Growth Factor Expression by Peroxisome Proliferator-activated Receptors in Bladder Cancer Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.019

10.1016/J.UROLOGY.2004.10.019

7 January 2021

Identifiers

DOI

1 reference

21 December 2017

release_lnt5erxgvve5jc63icdffam7g4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lnt5erxgvve5jc63icdffam7g4

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

15780399

1 reference

21 December 2017